Allicin is a potential hypolipidemic and antiatherogenic agent: Mechanisms of action and implicated signaling pathways

Sham A. Al Refaai, Mohammad A. Akram, Amin F. Majdalawieh

Open source

DOI
10.1016/j.ejphar.2026.179160
Published
2026-07
Container
European Journal of Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2026.179160,
  title = {Allicin is a potential hypolipidemic and antiatherogenic agent: Mechanisms of action and implicated signaling pathways},
  author = {Sham A. Al Refaai and Mohammad A. Akram and Amin F. Majdalawieh},
  year = {2026},
  journal = {European Journal of Pharmacology},
  doi = {10.1016/j.ejphar.2026.179160},
  url = {https://doi.org/10.1016/j.ejphar.2026.179160}
}

RIS

TY  - JOUR
TI  - Allicin is a potential hypolipidemic and antiatherogenic agent: Mechanisms of action and implicated signaling pathways
AU  - Sham A. Al Refaai
AU  - Mohammad A. Akram
AU  - Amin F. Majdalawieh
PY  - 2026
JO  - European Journal of Pharmacology
DO  - 10.1016/j.ejphar.2026.179160
UR  - https://doi.org/10.1016/j.ejphar.2026.179160
ER  - 

APA

Refaai, S. A. A., Akram, M. A., & Majdalawieh, A. F. (2026). Allicin is a potential hypolipidemic and antiatherogenic agent: Mechanisms of action and implicated signaling pathways. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2026.179160

Source records